Program Guide – ASCO Meeting Program Guide

The abstract will be released to the public on May 22, 2025 at 9:00 PM UTC Rahaf Omaish University of Arkansas for Medical Sciences, Little Rock, AR Rahaf Omaish, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee, Samer Al Hadidi University of Arkansas for Medical Sciences, Little Rock, AR, Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR, Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little

Read the full article here

Source: meetings.asco.org

Categories: General Medicine News

Tags: ASCO25,mmsm,CARTcell,hemepath

Tweets with this article

Mike Thompson, MD, PhD, FASCO

B-cell maturation antigen (BCMA) immunohistochemistry (IHC) staining in multiple myeloma (MM) patients with prior use of BCMA-based therapies - @RahafOmaish et al. #ASCO25 Abst e19540 https://t.co/97i83FqhUS #mmsm #CARTcell #hemepath

Homepage of Mark Cuban Cost Plus Drugs

Mark Cuban Cost Plus Drug homepage. Provides safe, affordable medicine or medication with transparent low prices.

Mike Thompson, MD, PhD, FASCO June 22, 2025

Homepage of Mark Cuban Cost Plus Drugs

Mark Cuban Cost Plus Drug homepage. Provides safe, affordable medicine or medication with transparent low prices.

Mike Thompson, MD, PhD, FASCO June 22, 2025

#YellowFever – Healthcare Social Media Analytics and Transcripts

Yellow Fever is an acute viral hemorrhagic disease that is spread by the bite of mosquitoes. Early stage symptoms may include headache, muscle and joint

Mike Thompson, MD, PhD, FASCO June 22, 2025

Protecting Travelers Against Yellow Fever in a Time of Vaccine Shortages

This Viewpoint examines strategies for vaccinating travelers against yellow fever given recent vaccine shortages and global yellow fever outbreaks.

Mike Thompson, MD, PhD, FASCO June 22, 2025

Yellow Fever — Once Again on the Radar Screen in the Americas | NEJM

Sylvatic transmission cycles of yellow fever continue to occur in endemic tropical regions. If the outbreak in Brazil leads to urban spread, U.S. clinicians should…

Mike Thompson, MD, PhD, FASCO June 22, 2025

Not So BenignAntiphospholipid Antibody Syndrome: Clots, Complement, and Catastrophe!

Antiphospholipid syndrome (APS) is a thromboinflammatory disorder characterized by thrombosis and/or recurrent fetal loss accompanied by persistently positive t

Mike Thompson, MD, PhD, FASCO June 20, 2025

Paper: Proteomic Profiling of Different Antiphospholipid Antibody-Positive Phenotypes: Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Registry

Program: Oral and Poster Abstracts Session: 301. Vasculature, Endothelium, Thrombosis and Platelets: Basic and Translational: Poster II Hematology Disease Topics & Pathways: Research, Bleeding and…

Mike Thompson, MD, PhD, FASCO June 20, 2025

Related Articles